Albert D. Dyrness - Net Worth and Insider Trading
Albert D. Dyrness Net Worth
The estimated net worth of Albert D. Dyrness is at least $47,787 dollars as of 2024-05-27. Albert D. Dyrness is the Director of Sonnet BioTherapeutics Holdings Inc and owns about 28,962 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $47,787. Details can be seen in Albert D. Dyrness's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Albert D. Dyrness has not made any transactions after 2023-05-30 and currently still holds the listed stock(s).
Transaction Summary of Albert D. Dyrness
Albert D. Dyrness Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Albert D. Dyrness owns 2 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) , and Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Albert D. Dyrness’s form 4 insider trades.
Insider Ownership Summary of Albert D. Dyrness
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-30 | director |
| OTLK | Outlook Therapeutics Inc | 2016-05-12 | director |
Albert D. Dyrness Latest Holdings Summary
Albert D. Dyrness currently owns a total of 1 stock. Albert D. Dyrness owns 28,962 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of May 30, 2023, with a value of $47,787.
Latest Holdings of Albert D. Dyrness
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-30 | 28,962 | 1.65 | 47,787 |
Holding Weightings of Albert D. Dyrness
Albert D. Dyrness Form 4 Trading Tracker
According to the SEC Form 4 filings, Albert D. Dyrness has made a total of 2 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 23,255 shares on May 30, 2023, which cost Albert D. Dyrness around $10,930.
Insider Trading History of Albert D. Dyrness
- 1
Albert D. Dyrness Trading Performance
GuruFocus tracks the stock performance after each of Albert D. Dyrness's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert D. Dyrness is -38.76%. GuruFocus also compares Albert D. Dyrness's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert D. Dyrness within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Albert D. Dyrness's insider trading performs compared to the benchmark.
Performance of Albert D. Dyrness
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.57 | | | | | |
| Relative Return to S&P 500(%) | -12.52 | | | | | |
Albert D. Dyrness Ownership Network
Albert D. Dyrness Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Albert D. Dyrness is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Albert D. Dyrness made 1 insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN) with a net purchase of 23,255. Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 431,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 10,000 shares made by Susan Dexter .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 489,855 shares were bought by its insiders, resulting in a net purchase of 489,855 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Albert D. Dyrness Mailing Address
Above is the net worth, insider trading, and ownership report for Albert D. Dyrness. You might contact Albert D. Dyrness via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
